Polycystic Kidney Disease Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Polycystic Kidney Disease?
Polycystic kidney disease (PKD) is an inherited genetic disorder in which numerous fluid-filled cysts develop in the kidneys. As cysts grow and multiply, the kidneys may become enlarged, and their ability to filter blood can gradually decline. PKD can also affect organs outside the kidneys, particularly the liver and blood vessels. The two main forms are autosomal dominant PKD (ADPKD), which usually develops in adulthood, and autosomal recessive PKD (ARPKD), which often presents during infancy or childhood.
What is the Importance of Timely Treatment?
PKD may progress gradually without noticeable symptoms in its early stages. Timely diagnosis and regular monitoring can help detect high blood pressure, declining kidney function, increasing kidney volume and other complications. In adults with ADPKD who are at risk of rapid disease progression, appropriate assessment can help identify patients who may benefit from disease-modifying treatment such as tolvaptan. Early management of blood pressure and other complications can also help protect kidney function.
What are the Common Symptoms of Polycystic Kidney Disease?
- Pain in the back, sides or abdomen
- High blood pressure
- Blood in the urine
- Recurrent urinary tract or kidney cyst infections
- Kidney stones
- Increased abdominal fullness due to enlarged kidneys or liver cysts
- Headaches
- Fatigue
- Frequent urination or other urinary changes
- Reduced kidney function
- Swelling in advanced kidney disease
- Symptoms related to kidney failure in severe disease
Causes and Risk Factors of Polycystic Kidney Disease
Causes
- PKD is caused by disease-causing genetic variants that affect kidney cell development and function. ADPKD is most commonly associated with variants in the PKD1 or PKD2 genes and is usually inherited from one affected parent.
- ARPKD is caused by variants in the PKHD1 gene and occurs when a child inherits disease-causing variants from both parents.
- In some cases, a new genetic variant may occur without a known family history.
Risk Factors
- Having a parent with ADPKD
- Family history of PKD
- Inheriting disease-causing variants associated with PKD
- Having a sibling or close relative with PKD
- Genetic factors associated with more rapid disease progression
- High blood pressure, which can accelerate kidney damage
- Increasing kidney size or total kidney volume in ADPKD
- Reduced kidney function or evidence of rapid eGFR decline
Latest Research and Technologies in the Treatment of Polycystic Kidney Disease in India
- Recent advances in PKD management focus on early diagnosis, imaging-based risk assessment and slowing disease progression. MRI and other advanced imaging techniques can help quantify kidney size and cyst burden, while genetic testing can support diagnosis and family counselling in selected patients. Research continues into additional disease-modifying therapies, biomarkers and approaches aimed at slowing cyst growth and kidney-function decline.
Treatment options for Polycystic Kidney Disease
Peritoneal Dialysis (PD) : PD offers excellent, continuous fluid removal, gentler blood pressure control, and spares the patient from frequent needle sticks, making it a highly popular home-based option.
Cost Start From 70Explore Options
Hemodialysis (HD) : Hemodialysis allows for aggressive fluid removal during sessions to help manage fluid-dependent hypertension.
Cost Start From 80Explore Options
Kidney Transplantation : Advanced PKD may eventually cause kidney failure. Patients with kidney failure may require hemodialysis, peritoneal dialysis or kidney transplantation depending on their medical condition and eligibility.
Cost Start From 10000Explore Options
- Clinical assessment:
- Medical and Nephrological Evaluation: A detailed history assesses family history of PKD, blood pressure, urinary symptoms, flank or abdominal pain, kidney stones, urinary infections, blood in the urine and symptoms of declining kidney function.
- Kidney Function Assessment: Blood tests, including serum creatinine and estimated glomerular filtration rate (eGFR), assess kidney function. Urinalysis and urine protein or albumin measurements may help identify additional kidney abnormalities.
- Blood Pressure Assessment: Regular blood-pressure measurement is important because hypertension is common in ADPKD and can contribute to faster kidney-function decline and cardiovascular complications.
- Family and Genetic Assessment: A detailed family history can help identify inherited disease. Genetic testing may be considered when the diagnosis is uncertain, when there is no clear family history, for selected living kidney donors, or when information is needed for family or reproductive counselling.
- Risk and Prognostic Assessment: In adults with ADPKD, clinicians may assess the likelihood of rapid progression using kidney size, eGFR trajectory, age, and the PROPKD score. These assessments can help determine whether to consider disease-modifying treatment.
- Imaging Tests:
- Renal Ultrasound: Commonly used to detect kidney cysts and assess kidney size and structure.
- Magnetic Resonance Imaging (MRI): Provides detailed assessment of kidney and cyst volume and can support Mayo Imaging Classification for risk stratification.
- Computed Tomography (CT): May provide detailed anatomical information and can help evaluate kidney stones, bleeding, cyst complications or other abdominal conditions. Low-dose CT may also be considered for kidney-volume assessment when MRI is unavailable or unsuitable.
- Liver Imaging: Ultrasound, CT or MRI may be used to evaluate liver cysts and other abdominal complications.
- Brain Vascular Imaging: Magnetic resonance angiography (MRA) may be considered in selected patients to evaluate intracranial aneurysms, particularly when clinical or family-history factors indicate increased risk.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Polycystic Kidney Disease patients in India. These Services include:
- Physical Activity and Exercise: Regular, appropriate physical activity can help maintain strength, cardiovascular health and healthy body weight. Adapt activities when enlarged kidneys, pain, or other complications limit certain movements.
- Pain and Mobility Management: Physiotherapy may help patients manage chronic musculoskeletal discomfort, improve posture and maintain safe mobility. Patients with significantly enlarged or symptomatic kidneys may need individual assessment for high-impact or contact activities.
- Nutritional Support: A renal dietitian can guide sodium intake, healthy weight management, hydration, and other dietary considerations based on kidney function and blood pressure.
- Fatigue and Energy Management: Activity planning, adequate sleep, appropriate exercise and management of anemia or advanced kidney disease can help reduce the effect of fatigue on daily activities.
- Psychological and Long-Term Support: Counselling, genetic counselling and patient education can help individuals and families cope with an inherited condition, long-term monitoring, reproductive considerations and the possibility of future kidney replacement therapy.
- Medicines for PKD are used to control blood pressure, manage symptoms and, in selected patients with rapidly progressive ADPKD, slow the decline in kidney function. ACE inhibitors or ARBs may be used for blood-pressure control, while other antihypertensive medicines may be added when required. Pain medicines and antibiotics may be prescribed for cyst-related pain, infections, or other complications, depending on the underlying cause.
Instantly Connect with our Specialists
Hospitals for Polycystic Kidney Disease in India
Global Health City
Chennai, India
The Hospital has world-class infrastructure with a capacity of over 1000 beds and much more-
- 265 Licensed beds
- 13 Operation Theatres
- 24*7 Cath Lab
- 24*7 available Blood Bank
- 24*7 Emergency Department
- 24*7 Open Pharmacy
Apollo Hospitals
Hyderabad, India
Apollo Hospitals located in Hyderabad, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
- A premier multi-specialty hospital with 477-bed capacity
- More than 50 specialties, super-specialties
- 12 Centers of Excellence
- The Institutes for Heart Diseases, Neurosciences, Cancer, Emergency, Orthopaedics, Renal Diseases, and Transplants
- Centers of Excellence are known for patient care, training and research
- Doctors with years of truly global experience in healthcare delivery
Artemis Health Institute
Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Polycystic Kidney Disease Treatment?
- Multidisciplinary Nephrology Care: Patients can access nephrologists, urologists, genetic specialists, radiologists, transplant specialists, and other professionals as needed.
- Advanced Diagnostic Facilities: Major centres may provide renal ultrasound, MRI, CT, genetic testing, kidney-function assessment and imaging-based progression-risk evaluation.
- Disease-Modifying Treatment: Eligible patients with rapidly progressive ADPKD may be evaluated for treatments such as tolvaptan under specialist supervision.
- Kidney Replacement Therapy: Advanced kidney centres can provide hemodialysis, peritoneal dialysis and kidney transplantation for patients who develop kidney failure.
- Comprehensive International Patient Support: Major hospitals may provide medical-record review, specialist consultations, treatment coordination, accommodation assistance and follow-up care for international patients.